Our study on the circulating plasma proteome of prurigo nodularis (PN) patients just dropped https://t.co/wA2g0CTSoK in @JAADjournals. Led by @vparthas, we show dz heterogeneity and endotypes in line w/the variable response to tx we see clinically @HopkinsMedicine#dermtwitter
Hot off the press - great work by @vparthas & team confirming our clinical suspicions that prurigo nodularis has unique disease endotypes relating to Type 2 inflammation @ https://t.co/vQqj67qK0i #dermtwitter
Happy to share our latest work led by @vparthas https://t.co/ABMNl3tWZG. Components of Type 2 inflammation are increased in subsets of Prurigo Nodularis (PN) patients - circulating IL-13 and periostin (also key in systemic sclerosis). We also find disease clusters #dermtwitter
Finally, at 11:33AM watch @chiragvasavda in C123-124 present the first genetic sequencing study of #prurigonodularis where we uncover racial and ancestral differences in susceptibility to #PN in @SkinofColor patients
Then join us in the @SkinofColor symposium in C123-124 at 10:57AM to racial differences in circulating blood inflammatory biomarkers in hidradenitis suppurativa #HS
First up, join us in Rooms A105-106 from 10:09-10:21 am to learn about a novel method of TMT tissue triggered plasma proteomics from an interventional trial of IL-31 blockade in patients with #prurigonodularis